Alimera Begin Period Cash Flow from 2010 to 2024
| ALIM Stock | USD 2.89 0.12 3.99% |
Begin Period Cash Flow | First Reported 2007-03-31 | Previous Quarter 8.3 M | Current Value 12.1 M | Quarterly Volatility 15 M |
Check Alimera Sciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Alimera Sciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 9.2 M, Interest Expense of 10.7 M or Selling General Administrative of 11.1 M, as well as many indicators such as Price To Sales Ratio of 1.3, Dividend Yield of 0.0 or PTB Ratio of 2.51. Alimera financial statements analysis is a perfect complement when working with Alimera Sciences Valuation or Volatility modules.
Alimera | Begin Period Cash Flow |
Latest Alimera Sciences' Begin Period Cash Flow Growth Pattern
Below is the plot of the Begin Period Cash Flow of Alimera Sciences over the last few years. It is the amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities. Alimera Sciences' Begin Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Alimera Sciences' overall financial position and show how it may be relating to other accounts over time.
| Begin Period Cash Flow | 10 Years Trend |
|
Begin Period Cash Flow |
| Timeline |
Alimera Begin Period Cash Flow Regression Statistics
| Arithmetic Mean | 24,676,253 | |
| Geometric Mean | 18,963,292 | |
| Coefficient Of Variation | 76.70 | |
| Mean Deviation | 13,583,931 | |
| Median | 22,815,000 | |
| Standard Deviation | 18,925,956 | |
| Sample Variance | 358.2T | |
| Range | 71.7M | |
| R-Value | (0.54) | |
| Mean Square Error | 272T | |
| R-Squared | 0.29 | |
| Significance | 0.04 | |
| Slope | (2,298,309) | |
| Total Sum of Squares | 5014.7T |
Alimera Begin Period Cash Flow History
About Alimera Sciences Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Alimera Sciences income statement, its balance sheet, and the statement of cash flows. Alimera Sciences investors use historical funamental indicators, such as Alimera Sciences's Begin Period Cash Flow, to determine how well the company is positioned to perform in the future. Although Alimera Sciences investors may use each financial statement separately, they are all related. The changes in Alimera Sciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Alimera Sciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Alimera Sciences Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Alimera Sciences. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Begin Period Cash Flow | 5.3 M | 5 M |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Alimera Sciences using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Additional Information and Resources on Investing in Alimera Stock
When determining whether Alimera Sciences is a strong investment it is important to analyze Alimera Sciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Alimera Sciences' future performance. For an informed investment choice regarding Alimera Stock, refer to the following important reports:Check out the analysis of Alimera Sciences Correlation against competitors. To learn how to invest in Alimera Stock, please use our How to Invest in Alimera Sciences guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alimera Sciences. If investors know Alimera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alimera Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.25) | Revenue Per Share 2.413 | Quarterly Revenue Growth 0.699 | Return On Assets (0.01) | Return On Equity (1.97) |
The market value of Alimera Sciences is measured differently than its book value, which is the value of Alimera that is recorded on the company's balance sheet. Investors also form their own opinion of Alimera Sciences' value that differs from its market value or its book value, called intrinsic value, which is Alimera Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alimera Sciences' market value can be influenced by many factors that don't directly affect Alimera Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alimera Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Alimera Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alimera Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.